Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer

Autor: Harter, Philipp, Sehouli, Jalid, Vergote, Ignace, Ferron, Gwenael, Reuss, Alexander, Meier, Werner, Greggi, Stefano, Mosgard, Berit J, Selle, Frederic, Guyon, Frédéric, Pomel, Christophe, Lécuru, Fabrice, Zang, Rongyu, Avall-Lundqvist, Elisabeth, Kim, Jae-Weon, Ponce, Jordi, Raspagliesi, Francesco, Kristensen, Gunnar, Classe, Jean-Marc, Hillemanns, Peter, Jensen, Pernille, Hasenburg, Annette, Ghaem-Maghami, Sadaf, Mirza, Mansoor R, Lund, Bente, Reinthaller, Alexander, Santaballa, Ana, Olaitan, Adeola, Hilpert, Felix, du Bois, Andreas, S Buchholz, A Burges, U Canzler, D Denschlag, A El-Balat, G Emons, R Felberbaum, N de Gregorio, M Gropp-Meier, V Hanf, L Hanker, R Hils, C Kurzeder, B Lampe, A Mustea, M Schmidt, R Schutz, M Weigel, S Weiser, A Zorr, C Marth, E Petru, T Scholl, M Beltran, I Bover, A Gomez di Laino, N Lainez, S Martinez, A Poveda Velasco, M Romeo, H Crouet, E de Gournay, G Deplanque, P Follana, A Floquet, D Lanvin, J Leveque, E Pujade-Lauraine, N Raban, B Resch, A M Savoye, G Aletti, G Giorda, F Landoni, C Scaffa, J Abu, F Alexander-Sefre, D Barton, S Butler-Manuel, R Clayton, R Crawford, T Duncan, A El-Ghobashy, C Fotopoulou, M Hall, C Intrivici, A Lawrence, D Luesley, R Naik, A Nordin, J Tidy, L Fokdahl, A Hofsjö, P Kjolhede, B Eyjolfsdottir, Z Y Dai, P Zhang, B Aminossadati, M Hahmann, C Nasemann, S Yahiaoui, M Wittenberg, C Schade-Brittinger, G Elser, D Reddig, M Kuncke, S Polleis, Y Mattukat, A Riha, R Berger, J de Roover, B Kaur, J Crook, F Nepote, B Votan, M Andriamamonjy, J Bryce, S Ristinge

Publikováno v: Harter, P, Sehouli, J, Vergote, I, Ferron, G, Reuss, A, Meier, W, Greggi, S, Mosgard, B J, Selle, F, Guyon, F, Pomel, C, Lécuru, F, Zang, R, Avall-Lundqvist, E, Kim, J-W, Ponce, J, Raspagliesi, F, Kristensen, G, Classe, J-M, Hillemanns, P, Jensen, P, Hasenburg, A, Ghaem-Maghami, S, Mirza, M R, Lund, B, Reinthaller, A, Santaballa, A, Olaitan, A, Hilpert, F, du Bois, A & DESKTOP III Investigators 2021, ' Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer ', The New England Journal of Medicine, vol. 385, no. 23, pp. 2123-2131 . https://doi.org/10.1056/NEJMoa2103294
NEW ENGLAND JOURNAL OF MEDICINE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Harter, P, Sehouli, J, Vergote, I, Ferron, G, Reuss, A, Meier, W, Greggi, S, Mosgard, B J, Selle, F, Guyon, F, Pomel, C, Lécuru, F, Zang, R, Avall-Lundqvist, E, Kim, J W, Ponce, J, Raspagliesi, F, Kristensen, G, Classe, J M, Hillemanns, P, Jensen, P, Hasenburg, A, Ghaem-Maghami, S, Mirza, M R, Lund, B, Reinthaller, A, Santaballa, A, Olaitan, A, Hilpert, F & Du Bois, A 2021, ' Randomized trial of cytoreductive surgery for relapsed ovarian cancer ', New England Journal of Medicine, vol. 385, no. 23, pp. 2123-2131 . https://doi.org/10.1056/NEJMoa2103294

BACKGROUND: Treatment for patients with recurrent ovarian cancer has been mainly based on systemic therapy. The role of secondary cytoreductive surgery is unclear. METHODS: We randomly assigned patients with recurrent ovarian cancer who had a first r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f31361614653d123d3ce643aeba6c3
https://vbn.aau.dk/da/publications/7ebaa8eb-4c70-44c3-82d4-fe478c1c7475